[1]
|
Tao, X., Li, T., Gandomkar, Z., et al. (2023) Incidence, Mortality, Survival, and Disease Burden of Breast Cancer in China Compared to Other Developed Countries. Asia-Pacific Journal of Clinical Oncology, 19, 645-654. https://doi.org/10.1111/ajco.13958
|
[2]
|
Scimeca, M., Trivigno, D., Bonfiglio, R., et al. (2021) Breast Cancer Metastasis to Bone: From Epithelial to Mesenchymal Transition to Breast Osteoblast-Like Cells. Seminars in Cancer Biology, 72, 155-164. https://doi.org/10.1016/j.semcancer.2020.01.004
|
[3]
|
Sakata, T., Maeda, H., Yamasaki, K., et al. (1982) [Evaluation of CT and Demonstration of ECT Images on Skeletal Lesion in Cases of Post-Operative Breast Cancer]. Nihon Igaku Hoshasen Gakkai Zasshi, 42, 370-379.
|
[4]
|
Pan, Y., Lin, Y. and Mi, C. (2021) Clinicopathological Characteristics and Prognostic Risk Factors of Breast Cancer Patients with Bone Metastasis. Annals of Translational Medicine, 9, Article 1340. https://doi.org/10.21037/atm-21-4052
|
[5]
|
Zhang, J., Wei, Q., Dong, D., et al. (2021) The Role of TPS, CA125, CA15-3 and CEA in Prediction of Distant Metastasis of Breast Cancer. Clinica Chimica Acta, 523, 19-25. https://doi.org/10.1016/j.cca.2021.08.027
|
[6]
|
Feng, C., Zhan, Y., Shao, H., et al. (2020) Postoperative Expressions of TRACP5b and CA125 in Patients with Breast Cancer and Their Values for Monitoring Bone Metastasis. Journal of BUON, 25, 688-695.
|
[7]
|
赵庆杰, 尤军. 放射性核素骨显像联合血清CA125、CA15-3、CEA水平检测在乳腺癌骨转移诊断中的应用价值[J]. 河南医学研究, 2017, 26(21): 3871-3873.
|
[8]
|
Jiang, C., Hu, F., Xia, X., et al. (2023) Prognostic Value of Alkaline Phosphatase and Bone-Specific Alkaline Phosphatase in Breast Cancer: A Systematic Review and Meta-Analysis. The International Journal of Biological Markers, 38, 25-36. https://doi.org/10.1177/03936155231154662
|
[9]
|
Tayubi, I.A. and Madar, I.H. (2022) Biomineralization Associated Alkaline Phosphatase as a Potential Marker of Bone Metastasis in the Patients with Invasive Breast Cancer. Saudi Journal of Biological Science, 29, Article ID: 103340. https://doi.org/10.1016/j.sjbs.2022.103340
|
[10]
|
Wu, Q., Tian, P., He, D., et al. (2023) SCUBE2 Mediates Bone Metastasis of Luminal Breast Cancer by Modulating Immune-Suppressive Osteoblastic Niches. Cell Research, 33, 464-478. https://doi.org/10.1038/s41422-023-00810-6
|
[11]
|
Liu, M., Sui, L., Fang, Z., et al. (2023) Aberrant Expression of Bone Morphogenetic Proteins in the Disease Progression and Metastasis of Breast Cancer. Frontiers in Oncology, 13, Article 1166955. https://doi.org/10.3389/fonc.2023.1166955
|
[12]
|
Puppo, M., Valluru, M.K., Croset, M., et al. (2023) MiR-662 Is Associated with Metastatic Relapse in Early-Stage Breast Cancer and Promotes Metastasis by Stimulating Cancer Cell Stemness. British Journal of Cancer, 129, 754-771. https://doi.org/10.1038/s41416-023-02340-9
|
[13]
|
Chen, B., Dai, D., Tang, H., et al. (2016) Pre-Treatment Serum Alkaline Phosphatase and Lactate Dehydrogenase as Prognostic Factors in Triple Negative Breast Cancer. Journal of Cancer, 7, 2309-2316. https://doi.org/10.7150/jca.16622
|
[14]
|
Yoo, T.K., Chae, B.J., Kim, S.J., et al. (2017) Identifying Long-Term Survivors among Metastatic Breast Cancer Patients Undergoing Primary Tumor Surgery. Breast Cancer Research and Treatment, 165, 109-118. https://doi.org/10.1007/s10549-017-4309-2
|
[15]
|
Rao, H., Wu, H., Huang, Q., et al. (2021) Clinical Value of Serum CEA, CA24-2 and CA19-9 in Patients with Colorectal Cancer. Clinical Laboratory, 67. https://doi.org/10.7754/Clin.Lab.2020.200828
|
[16]
|
Corso, G., Gilardi, L., Girardi, A., et al. (2020) How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance? Oncology, 98, 714-718. https://doi.org/10.1159/000507707
|
[17]
|
Chen, W.Z., Shen, J.F., Zhou, Y., et al. (2017) Clinical Characteristics and Risk Factors for Developing Bone Metastases in Patients with Breast Cancer. Scientific Reports, 7, Article No. 11325. https://doi.org/10.1038/s41598-017-11700-4
|
[18]
|
Araz, M., Beypinar, I., Kazan, S., et al. (2019) Are Preoperative Serum CA15-3 Levels Different in Breast Cancer Subgroups? Current Problems in Cancer, 43, 115-122. https://doi.org/10.1016/j.currproblcancer.2018.06.011
|
[19]
|
熊炳钧, 黄静, 袁可玉, 等. 骨转换标志物与肿瘤标志物在骨转移诊断中的价值[J]. 肿瘤代谢与营养电子杂志, 2023, 10(5): 633-638.
|
[20]
|
Wang, X., Li, Y., Tong, J., et al. (2019) Endometriosis Presenting with Recurrent Massive Hemorrhagic Ascites and Diagnosed by Core Needle Biopsy: A Case Report. Medicine, 98, e15477. https://doi.org/10.1097/MD.0000000000015477
|
[21]
|
Lian, M., Zhang, C., Zhang, D., et al. (2019) The Association of Five Preoperative Serum Tumor Markers and Pathological Features in Patients with Breast Cancer. Journal of Clinical Laboratory Analysis, 33, e22875. https://doi.org/10.1002/jcla.22875
|
[22]
|
Levin, G., Herzberg, S., Dior, U.P., et al. (2019) The Predictive Role of CA-125 in the Management of Tubo-Ovarian Abscess. A Retrospective Study. European Journal of Obstetrics & Gynecology and Reproductive Biology, 238, 20-24. https://doi.org/10.1016/j.ejogrb.2019.05.004
|
[23]
|
Liu, M., Zhou, S., Wang, J., et al. (2019) Identification of Genes Associated with Survival of Breast Cancer Patients. Breast Cancer, 26, 317-325. https://doi.org/10.1007/s12282-018-0926-9
|
[24]
|
Stewart, A.F., Wu, T., Goumas, D., et al. (1987) N-Terminal Amino Acid Sequence of Two Novel Tumor-Derived Adenylate Cyclase-Stimulating Proteins: Identification of Parathyroid Hormone-Like and Parathyroid Hormone-Unlike Domains. Biochemical and Biophysical Research Communications, 146, 672-678. https://doi.org/10.1016/0006-291X(87)90581-X
|
[25]
|
Southby, J., Kissin, M.W., Danks, J.A., et al. (1990) Immunohistochemical Localization of Parathyroid Hormone-Related Protein in Human Breast Cancer. Cancer Research, 50, 7710-7716.
|
[26]
|
Grill, V., Ho, P., Body, J.J., et al. (1991) Parathyroid Hormone-Related Protein: Elevated Levels in Both Humoral Hypercalcemia of Malignancy and Hypercalcemia Complicating Metastatic Breast Cancer. The Journal of Clinical Endocrinology & Metabolism, 73, 1309-1315. https://doi.org/10.1210/jcem-73-6-1309
|
[27]
|
Powell, G.J., Southby, J., Danks, J.A., et al. (1991) Localization of Parathyroid Hormone-Related Protein in Breast Cancer Metastases: Increased Incidence in Bone Compared with Other Sites. Cancer Research, 51, 3059-3061.
|
[28]
|
Martin, T.J. and Johnson, R.W. (2021) Multiple Actions of Parathyroid Hormone-Related Protein in Breast Cancer Bone Metastasis. British Journal of Pharmacology, 178, 1923-1935. https://doi.org/10.1111/bph.14709
|
[29]
|
Yerram, P., Moore, R., Wolf, S., et al. (2019) Incidence of Skeletal Related Events in Patients with Bone Metastasis Receiving Denosumab Every Four Weeks Compared to Intervals Greater than Every Four Weeks. Journal of Oncology Pharmacy Practice, 25, 529-534. https://doi.org/10.1177/1078155217743074
|
[30]
|
Matuoka, J.Y., Kahn, J.G. and Secoli, S.R. (2019) Denosumab versus Bisphosphonates for the Treatment of Bone Metastases from Solid Tumors: A Systematic Review. The European Journal of Health Economics, 20, 487-499. https://doi.org/10.1007/s10198-018-1011-1
|
[31]
|
Nguyen, M.N., Akte, R.S., Akhter, H., et al. (2023) TOR1B: A Predictor of Bone Metastasis in Breast Cancer Patients. Scientific Reports, 13, Article No. 1495. https://doi.org/10.1038/s41598-023-28140-y
|
[32]
|
Haider, M.T., Ridlmaier, N., Smit, D.J., et al. (2021) Interleukins as Mediators of the Tumor Cell-Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis. International Journal of Molecular Sciences, 22, Article 2898. https://doi.org/10.3390/ijms22062898
|
[33]
|
Avalos-Navarro, G., Muñoz-Valle, J.F., Daneri-Navarro, A., et al. (2019) Circulating Soluble Levels of MIF in Women with Breast Cancer in the Molecular Subtypes: Relationship with Th17 Cytokine Profile. Clinical and Experimental Medicine, 19, 385-391. https://doi.org/10.1007/s10238-019-00559-6
|
[34]
|
Chen, X. and Cubillos-Ruiz, J.R. (2021) Endoplasmic Reticulum Stress Signals in the Tumour and Its Microenvironment. Nature Reviews Cancer, 21, 71-88. https://doi.org/10.1038/s41568-020-00312-2
|
[35]
|
Wang, X., Yu, J., Wen, H., et al. (2023) Antioxidative Stress Protein SRXN1 Can Be Used as a Radiotherapy Prognostic Marker for Prostate Cancer. BMC Urology, 23, Article No. 148. https://doi.org/10.1186/s12894-023-01319-1
|
[36]
|
Puppo, M., Valluru, M.K. and Clézardin, P. (2021) MicroRNAs and Their Roles in Breast Cancer Bone Metastasis. Current Osteoporosis Reports, 19, 256-263. https://doi.org/10.1007/s11914-021-00677-9
|
[37]
|
Gomarasca, M., Maroni, P., Banfi, G., et al. (2020) MicroRNAs in the Antitumor Immune Response and in Bone Metastasis of Breast Cancer: From Biological Mechanisms to Therapeutics. International Journal of Molecular Sciences, 21, Article 2805. https://doi.org/10.3390/ijms21082805
|
[38]
|
Shin, E. and Koo, J.S. (2020) The Role of Adipokines and Bone Marrow Adipocytes in Breast Cancer Bone Metastasis. International Journal of Molecular Sciences, 21, Article 4967. https://doi.org/10.3390/ijms21144967
|
[39]
|
Khan, S., Shukla, S., Sinha, S., et al. (2013) Role of Adipokines and Cytokines in Obesity-Associated Breast Cancer: Therapeutic Targets. Cytokine & Growth Factor Reviews, 24, 503-513. https://doi.org/10.1016/j.cytogfr.2013.10.001
|
[40]
|
Soni, S., Torvund, M. and Mandal, C.C. (2021) Molecular Insights into the Interplay between Adiposity, Breast Cancer and Bone Metastasis. Clinical & Experimental Metastasis, 38, 119-138. https://doi.org/10.1007/s10585-021-10076-0
|